IL-17 potential therapeutic target for pustular psoriasis
Researchers performed a systematic review of available reports on the therapeutic benefit of interleukin (IL)-17/T-helper 17 (Th17) axis inhibitors in patients with generalized pustular psoriasis (GPP). Read what they discovered in this article.
 
ADVERTISEMENT
 
 
 
Socioeconomic factors affect psoriasis treatment outcomes
A recent, extreme case of psoriasis demonstrates how socioeconomic factors can lead to inadequate disease control. The solution? A personalized treatment plan, says the study authors.